Free Trial
NASDAQ:DMAAU

Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

Drugs Made in America Acquisition logo
$10.50 0.00 (0.00%)
As of 07/25/2025

About Drugs Made in America Acquisition Stock (NASDAQ:DMAAU)

Key Stats

Today's Range
$10.50
$10.50
50-Day Range
$10.25
$10.50
52-Week Range
$10.00
$10.82
Volume
1,748 shs
Average Volume
42,042 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMAAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made in America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DMAAU Stock News Headlines

DMAAU Drugs Made In America Acquisition Corp. Units
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
DMAA Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp
See More Headlines

DMAAU Stock Analysis - Frequently Asked Questions

Drugs Made in America Acquisition's stock was trading at $10.00 on January 1st, 2025. Since then, DMAAU stock has increased by 5.0% and is now trading at $10.50.

Drugs Made in America Acquisition (DMAAU) raised $200 million in an initial public offering (IPO) on Tuesday, January 28th 2025. The company issued 20,000,000 shares at a price of $10.00 per share. Clear Street served as the underwriter for the IPO.

Drugs Made in America Acquisition's lock-up period expires on Monday, July 28th. Drugs Made in America Acquisition had issued 20,000,000 shares in its IPO on January 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Investment Offices
Sub-Industry
Trading
Current Symbol
NASDAQ:DMAAU
CIK
2028614
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:DMAAU) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners